Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202
European Urology Focus · 2024
DOI: 10.1016/j.euf.2024.01.008 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Urology Focus, 2024. Verfasst von Kimberley S Mak und 22 weiteren Autor:innen. Beteiligte Einrichtung: Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. Electronic address: kimberley.mak@bmc.org. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Androgen Antagonists, Cardiovascular Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
BACKGROUND: Androgen deprivation therapy (ADT) has been associated with coronary heart disease and myocardial infarction (MI) in prostate cancer patients, but controversy persists regarding its effects on cardiovascular mortality (CVM). OBJECTIVE: We assessed the long-term relationship between ADT and CVM in a prostate cancer randomized trial (NRG Oncology/Radiation Therapy Oncology Group 9202). DESIGN, SETTING, AND PARTICIPANTS: From 1992 to 1995, 1554 men with locally advanced prostate cancer (T2c-T4, prostate-specific antigen
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. Electronic address: kimberley.mak@bmc.org.
- University of Illinois Cancer Center, Chicago, IL, USA.
- University of Chicago, Chicago, IL, USA; NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA.
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
- Northeast Radiation Oncology Center, Dunmore, PA, USA.
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Mak, K. S., Scannell Bryan, M., Dignam, J. J., Shipley, W. U., Lin, Y., Peters, C. A., Gore, E. M., Rosenthal, S. A., Zeitzer, K. L., D'Souza, D. P., Horwitz, E. M., Pisansky, T. M., Maier, J. M., Chafe, S. M., Robin, T. P., Roach, M., Tran, P. T., Souhami, L., Michalski, J. M., …, & Efstathiou, J. A. (2024). Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202. European Urology Focus. https://doi.org/10.1016/j.euf.2024.01.008
Vancouver
Mak KS, Scannell Bryan M, Dignam JJ, Shipley WU, Lin Y, Peters CA, et al. Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202. European Urology Focus. 2024. doi:10.1016/j.euf.2024.01.008
BibTeX
@article{Mak2024,
author = {Mak, Kimberley S and Scannell Bryan, Molly and Dignam, James J and Shipley, William U and Lin, Yue and Peters, Christopher A and Gore, Elizabeth M and Rosenthal, Seth A and Zeitzer, Kenneth L and D'Souza, David P and Horwitz, Eric M and Pisansky, Thomas M and Maier, Jordan M and Chafe, Susan M and Robin, Tyler P and Roach, Mack and Tran, Phuoc T and Souhami, Luis and Michalski, Jeff M and Hartford, Alan C and Feng, Felix Y and Sandler, Howard M and Efstathiou, Jason A},
title = {Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202},
journal = {European Urology Focus},
year = {2024},
doi = {10.1016/j.euf.2024.01.008}
}
EUVIMED